Suppr超能文献

苎麻根提取物对HepG2 2.2.15细胞中乙型肝炎病毒产生的抑制作用。

Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells.

作者信息

Huang Kai-Ling, Lai Yiu-Kay, Lin Chih-Chien, Chang Jia-Ming

机构信息

Division of Research and Development, Development Center for Biotechnology, Xizhi City, Taipei County, Taiwan 221, China.

出版信息

World J Gastroenterol. 2006 Sep 21;12(35):5721-5. doi: 10.3748/wjg.v12.i35.5721.

Abstract

AIM

To explore the anti-hepatitis B virus (HBV) effects of Boehmeria nivea (B. nivea) root extract (BNE) by using the HepG2 2.2.15 cell model system.

METHODS

Hepatitis B surface antigen (HBsAg), hepatitis B virus e antigen (HBeAg), and HBV DNA were measured by using ELISA and real-time PCR, respectively. Viral DNA replication and RNA expression were determined by using Southern and Northern blot, respectively.

RESULTS

In HepG2 2.2.15 cells, HBeAg (60%, P < 0.01) and particle-associated HBV DNA (> 99%, P < 0.01) secretion into supernatant were significantly inhibited by BNE at a dose of 100 mg/L, whereas the HBsAg was not inhibited. With different doses of BNE, the reduced HBeAg was correlated with the inhibition of HBV DNA. The anti-HBV effect of BNE was not caused by its cytotoxicity to cells or inhibition of viral DNA replication and RNA expression.

CONCLUSION

BNE could effectively reduce the HBV production and its anti-HBV machinery might differ from the nucleoside analogues.

摘要

目的

利用HepG2 2.2.15细胞模型系统探讨苎麻根提取物(BNE)的抗乙型肝炎病毒(HBV)作用。

方法

分别采用酶联免疫吸附测定法(ELISA)和实时荧光定量聚合酶链反应(real-time PCR)检测乙型肝炎表面抗原(HBsAg)、乙型肝炎e抗原(HBeAg)及HBV DNA。分别采用Southern印迹法和Northern印迹法检测病毒DNA复制和RNA表达。

结果

在HepG2 2.2.15细胞中,100 mg/L剂量的BNE可显著抑制HBeAg(60%,P<0.01)和颗粒相关HBV DNA(>99%,P<0.01)分泌到上清液中,而对HBsAg无抑制作用。不同剂量的BNE作用下,HBeAg的降低与HBV DNA的抑制相关。BNE的抗HBV作用并非由其对细胞的细胞毒性或对病毒DNA复制及RNA表达的抑制所致。

结论

BNE可有效降低HBV的产生,其抗HBV机制可能与核苷类似物不同。

相似文献

1
Inhibition of hepatitis B virus production by Boehmeria nivea root extract in HepG2 2.2.15 cells.
World J Gastroenterol. 2006 Sep 21;12(35):5721-5. doi: 10.3748/wjg.v12.i35.5721.
2
Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
World J Gastroenterol. 2006 Jul 28;12(28):4492-7. doi: 10.3748/wjg.v12.i28.4492.
3
Inhibition of hepatitis B virus replication by pokeweed antiviral protein in vitro.
World J Gastroenterol. 2008 Mar 14;14(10):1592-7. doi: 10.3748/wjg.14.1592.
4
Involvement of GRP78 in inhibition of HBV secretion by Boehmeria nivea extract in human HepG2 2.2.15 cells.
J Viral Hepat. 2009 May;16(5):367-75. doi: 10.1111/j.1365-2893.2009.01072.x. Epub 2009 Feb 17.
5
Inhibition of hepatitis B virus gene expression and replication by artificial microRNA.
World J Gastroenterol. 2008 Aug 7;14(29):4684-9. doi: 10.3748/wjg.14.4684.
6
Combination of small interfering RNA and lamivudine on inhibition of human B virus replication in HepG2.2.15 cells.
World J Gastroenterol. 2007 Apr 28;13(16):2324-7. doi: 10.3748/wjg.v13.i16.2324.
7
Inhibition of hepatitis B virus expression and replication by RNA interference in HepG2.2.15.
World J Gastroenterol. 2006 Oct 7;12(37):6046-9. doi: 10.3748/wjg.v12.i37.6046.
8
Epigallocatechin gallate inhibits HBV DNA synthesis in a viral replication - inducible cell line.
World J Gastroenterol. 2011 Mar 21;17(11):1507-14. doi: 10.3748/wjg.v17.i11.1507.
9
JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
Biomed Pharmacother. 2017 Aug;92:989-997. doi: 10.1016/j.biopha.2017.05.141. Epub 2017 Jun 8.

引用本文的文献

1
Isolation of GLP-1 enhancing indolizidine alkaloids from Boehmeria formosana.
J Food Drug Anal. 2023 Dec 15;31(4):739-771. doi: 10.38212/2224-6614.3483.
2
NS3/4A helicase inhibitory alkaloids from as HCV target.
RSC Adv. 2021 Oct 6;11(52):32740-32749. doi: 10.1039/d1ra06139a. eCollection 2021 Oct 4.
4
Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19.
Front Pharmacol. 2021 May 12;12:652335. doi: 10.3389/fphar.2021.652335. eCollection 2021.
5
Natural Plant Products: A Less Focused Aspect for the COVID-19 Viral Outbreak.
Front Plant Sci. 2020 Oct 15;11:568890. doi: 10.3389/fpls.2020.568890. eCollection 2020.
6
Genomics approaches to synthesize plant-based biomolecules for therapeutic applications to combat SARS-CoV-2.
Genomics. 2020 Nov;112(6):4322-4331. doi: 10.1016/j.ygeno.2020.07.033. Epub 2020 Jul 25.
7
Potentials of plant-based substance to inhabit and probable cure for the COVID-19.
Turk J Biol. 2020 Jun 21;44(3):228-241. doi: 10.3906/biy-2005-114. eCollection 2020.
8
9
Identification of anti-HBV activities in Andr. using GRP78 as a drug target on Herbochip.
Chin Med. 2017 Apr 24;12:11. doi: 10.1186/s13020-017-0132-2. eCollection 2017.

本文引用的文献

2
Virologic response and resistance to adefovir in patients with chronic hepatitis B.
J Hepatol. 2006 Feb;44(2):283-90. doi: 10.1016/j.jhep.2005.10.018. Epub 2005 Nov 15.
4
Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to Lamivudine.
Antimicrob Agents Chemother. 2004 Sep;48(9):3498-507. doi: 10.1128/AAC.48.9.3498-3507.2004.
5
6
Commonly used herbal medicines in the United States: a review.
Am J Med. 2004 Apr 1;116(7):478-85. doi: 10.1016/j.amjmed.2003.10.036.
7
Hepatitis B virus infection--natural history and clinical consequences.
N Engl J Med. 2004 Mar 11;350(11):1118-29. doi: 10.1056/NEJMra031087.
8
Mechanisms of action of interferon and nucleoside analogues.
J Hepatol. 2003;39 Suppl 1:S93-8. doi: 10.1016/s0168-8278(03)00207-1.
10
Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase.
Gastroenterology. 2003 Aug;125(2):292-7. doi: 10.1016/s0016-5085(03)00939-9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验